RELATIONAL PSYCHOTHERAPY PARENTING

该第一阶段项目的目标是(1)开发和试运行20- 阿片类药物成瘾者的周关系心理治疗父母教养小组 母亲，以及(2)制定和完善治疗师培训手册，以及 治疗师能力/依从性评分表，针对此治疗性 干预。阿片成瘾的母亲有未成年子女的情结 治疗需要与他们的高水平并存有关 精神病理学，以及一系列养育技能的缺陷。 尽管最近已经开发了几种治疗方案 专门针对上瘾的女性和母亲的，相对较少 系统地提供心理治疗服务和育儿技能 训练。在提供这种服务的情况下，缺乏 干预措施的文件化和人性化限制了可行性 培训/传播。 RPPG干预的发展是基于原则和 人际治疗技术(IPT)、互动式团体治疗、 以及对妇女待遇有性别敏感认识的观点。而不是 试图通过说教的方式对女性进行育儿教育， 心理教育讲座(目前许多节目中的常态)，育儿 将在支持性的背景下提供技能培训 对患者需求敏感的心理治疗干预 作为女性和母亲。对这种方法进行测试的初步尝试 在四周多的时间里，得到了积极的回应。与会者出席了 定期组织，并强烈支持这种做法的有用性和可取性 这种干预的可能性。 在拟议的研究中，RPPG干预将分两个阶段进行试验 网站：一个标准的美沙酮维持计划，包括男性和 女性，还有一个专门针对女性。在进行了一次“预试飞”之后 指导手册、评级的初始开发的干预措施 关于量表和培训材料，将进行两项试点干预 在两个地点中的每个地点按顺序进行，并有四个并发试点 涉及治疗的对照组，通常在每个 诊所。这些按顺序实施的干预措施将指导正在进行的 完善培训材料和治疗师的忠诚度/能力 评级等级。多信息者和多特质前后评估 将评估RPPG可能修改的区域 治疗。在这些努力的基础上，在三年期结束时， 我们预计将有方法和试点数据来支持更多 RPPG干预的广泛随机疗效试验，我们 预期不仅会直接使阿片成瘾的母亲受益，而且 此外，还会间接帮助他们的未成年子女。

The goals of this Phase I project are to (1) develop and pilot test a 20- week Relational Psychotherapy Parenting Group (RPPG) for opioid addicted mothers, and (2) to develop and refine a therapist training manual, and therapist competence/adherence rating scales, for this therapeutic intervention. Opioid addicted mothers of minor children have complex treatment needs related both to their high levels of comorbid psychopathology, and to a range of deficits in parenting skills. Although several treatment programs have recently been developed specifically for addicted women and mothers, relatively few systematically offer psychotherapeutic services and parenting skills training. In cases where such services are offered, the lack of documentation and manualization of interventions limits the feasibility of training/dissemination. Development of the RPPG intervention is based on principles and techniques of interpersonal Therapy (IPT), interactional group therapy, and gender sensitive perspectives on treatment for women. Rather than attempting to 'educate' women about parenting issues via didactic, psychoeducational lectures (the norm in many current programs), parenting skills training will be offered within the context of supportive psychotherapeutic interventions that are sensitive to the patients' needs as women and as mothers. A preliminary attempt to test this approach over four weeks met with a positive response. Participants attended the groups regularly, and strongly endorsed the usefulness and desirability of such an intervention. In the proposed study, the RPPG intervention will be piloted in two sites: a standard methadone maintenance program involving both males and females, and one targeted specifically at women. Following a 'pre-pilot' intervention that will guide initial development of the manual, rating scales, and training materials, two pilot interventions will be conducted in sequence at each of the two sites, with four concurrent pilot comparison groups involving the treatment typically offered at each clinic. These sequentially implemented interventions will guide ongoing refinements of training materials and therapist adherence/competence rating scales. Multi-informant and multi-trait pre- and post-assessments will be made to assess areas potentially modifiable with the RPPG treatment. Based on these efforts, at the end of a three-year period, we anticipate having the methods and pilot data to support a more extensive randomized efficacy trial of the RPPG intervention, that we anticipate will not only directly benefit opioid addicted mothers, but also, will indirectly help their minor children.